Navigation Links
Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.
Date:4/22/2010

Company To Produce Ingredients for Follow-on Biologics in Chicago.

Chicago (Vocus) April 22, 2010 -- Therapeutic Proteins Inc. (TPI) today announced the completion of the nation’s first independent, dedicated, follow-on biologics (or biosimilars) manufacturing facility constructed to meet U.S. Food and Drug Administration (FDA) requirements. The Chicago facility is located at University Technology Park at IIT (Illinois Institute of Technology).

Therapeutic Proteins Inc. has developed several off-patent biological drugs (recombinant proteins) used as life-saving therapies and which comprise a significant part of the total biological drugs market of around $40B. TPI only produces the therapeutic proteins as active pharmaceutical ingredients (API) for pharmaceutical manufacturers to formulate, package and sell these products to consumers. With the completion of the company’s new manufacturing facility in the U.S., TPI will be able to produce FDA-regulated API’s domestically, which goes against the trend of outsourcing manufacturing to other countries.

“We anticipate exporting bulk API in the fourth quarter of this year, and we will submit BLAs (biological license applications) to the FDA for new products once the agency establishes guidelines for biosimilars,” said Thomas L. Flynn III, CEO of Therapeutic Proteins. “The newly enacted healthcare bill directs the FDA to establish a regulatory framework for the marketing authorization of follow-on biologics.”

TPI currently has 13 employees, and the company expects to create more than two dozen new high-tech jobs in Ch
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
2. invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial
3. Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
4. Viron reports positive proof of concept results in arthritis for its VT-346 anti-TNF therapeutic
5. Cornerstone Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results
6. Foamix Ltd. and Therapeutics Inc. Enter Into Joint Venture to Develop New Prescription Foams for Inflammatory Skin Diseases - Will Target Over 20 Million Psoriasis and Atopic Dermatitis Patients
7. Sunlight Research(TM), Releases its Osiris Therapeutics Stem Cell Patent Report
8. Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MITs Technology Review
9. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
10. Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial
11. Cornerstone Therapeutics to Host Fourth Quarter and Full-Year 2009 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused ... analysis of tumor cells in the bloodstream, today announced ... decision support application powered by CollabRx, Inc. , ... test, Therapy Finder will provide breast cancer patients and ...
(Date:1/15/2014)... RedBrick Health , a fast-growing leader in consumer ... EmblemHealth , the New York ... the RedBrick Compass health assessment, combined with the RedBrick ... members. EmblemHealth is among the first health plans in ...
(Date:1/15/2014)... IPSWICH, England , January 15, 2014 ... to win races on the Formula 1 track could help ... between McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based ... funded by healthcare provider Simplyhealth. Telemetry technology, which ...
(Date:1/15/2014)... Two champions of science, technology, engineering, and mathematics ... competition for middle and high school students designed to ... The competition presents students with real-world problems experienced by ... and Sciences is a program administered by the ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... This release is available in German . ... at the Vienna University of Technology are interested in gold at ... most reactive catalysts for chemical reactions. However, when gold atoms are ... nuggets consisting of several atoms. A team of surface scientists now ...
... formation of a new Contract Research Organization (CRO), Agility ... providing customized clinical research and consulting services to small ... companies.  The Company was formed by David F. Hale, ... According to Hale, "Agility,s mission is to provide ...
... Inc. (NYSE: WPI ), a leading specialty ... President and Chief Executive Officer, will provide an overview ... Sachs Global Healthcare Conference 2012 on Wednesday, June 6, ... in Rancho Palos Verdes, California.  The presentation will be ...
Cached Biology Technology:The finest gold dust in the world 2Agility Clinical, Inc., a Specialty Contract Research Organization is Formed 2Watson to Present at Goldman Sachs Global Healthcare Conference 2012 2
(Date:4/23/2014)... the Indiana University School of Public Health-Bloomington has bolstered ... by finding a strong association between heme iron, found ... , The study found that heme iron consumption increased ... while no association was found between nonheme iron, which ... heart disease. , The study was published online ahead ...
(Date:4/23/2014)... that male black widow spiders prefer their female mates ... mate preference by male spiders. , The ... Andrade, a professor in UTSC,s Department of Biological Sciences, ... that males overwhelmingly chose to mate with well-fed, unmated ... whether a potential mate is well-fed and unmated by ...
(Date:4/23/2014)... accurate group decision increases with the abundance of brains ... a variety of factors as often happens in ... smaller groups actually tend to make more accurate decisions ... certain pieces of information. , The findings present a ... or the "wisdom of crowds," wherein individual observations ...
Breaking Biology News(10 mins):Study: Iron consumption can increase risk for heart disease 2Picky male black widow spiders prefer well-fed virgins 2Too many chefs: Smaller groups exhibit more accurate decision-making 2Too many chefs: Smaller groups exhibit more accurate decision-making 3
... New insights into the human immunodeficiency virus (HIV) infection ... now be possible through a research method recently developed ... Technology (NIST), where scientists have glimpsed an important protein ... known as Gag, plays several critical roles in the ...
... a lot going for it sweet, low calorie, high ... a pilot study led by food scientists at The Florida ... weapon against prehypertension, a precursor to cardiovascular disease. ... FSU Assistant Professor Arturo Figueroa and Professor Bahram H. Arjmandi ...
... Rochelle, NY, October 13, 2010Parents of children with undiagnosed ... host of psychological and social challenges, which are explored ... Testing and Molecular Biomarkers , a peer-reviewed journal published ... article is available free online ahead of print at ...
Cached Biology News:New look at multitalented protein sheds light on mysteries of HIV 2Florida State study finds watermelon lowers blood pressure 2Florida State study finds watermelon lowers blood pressure 3Unexplained childhood disorders 2
... is a modular confocal system that gives ... ultra-compact and lightweight design. The improved scan ... performance to 400nm andits bi-directional scanner provides ... X and Y scan axes rotation and ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... range of ergonomic microscopes are now available ... footprint. The DM-BA200 comes packed with Motic's ... exchangeable USB2.0 plug and play digital image ... mounted on a reversed quadruple nosepiece, deliver ...
Capture faint-light images without losing sensitivity or resolution. With its brand new hardware and interface design, the LAS-1000plus turns sample imaging into a simple process....
Biology Products: